PubMed Health⌕ Search

Biomedical subjects

T A Harrison

Publications and source records attributed to T A Harrison.

28 records · Page 2Linked to original sources

Antidromic response to medullary pyramid stimulation in rats and its relation to that in cats.

The response evoked in the cerebral cortex of laboratory rats after stimulation of the medullary pyramid is surface-positive. It begins 0.9-1.6 ms after the stimulus, attains peak amplitude (up to 2 mV) in 0.8-1.2 ms and lasts 2-4 ms. It occurs throughout the anterior two-thirds of the dorsal cortex and is largest lateral to bregma, with a secondary maximum in the somatosensory area II. Although it depends on antidromic conduction in pyramidal tract fibers for its production, it varies in amplitude, configuration and latency at different recording sites and at the same sites on repeated trials. It reverses polarity deep in the cortex to become a large, negative wave deep in layer V, and maintains that polarity into the white matter. Current source density analysis reveals a strong sink in layer V, with a strong source just superficial to that sink and a weaker source in layer VI. The antidromic response disappears during spreading depression, but recovers more rapidly than the primary response evoked by skin stimulation. It decreases progressively in amplitude with continuous 200-Hz iterative stimulation, and recovers slowly at the end of stimulation. The primary response evoked by contralateral forepaw and hindpaw stimulation is highly localized, being entirely within the antidromic response distribution. The antidromic response in laboratory rats consists of a small, surface-positive component analogous to the pure antidromic response of cats, and of a large, surface-positive response analogous to that found in woodchucks, rabbits, opossums and slow lorises. It is argued that this latter response results from synaptic action in pyramidal tract axon collaterals, probably onto cells in layer V, rather than being a purely antidromic event.

Afferent Pathways↗

Terminal deoxynucleotidyl transferase in the diagnosis of leukemia and malignant lymphoma.

Neoplastic cells from 253 patients with leukemia and 46 patients with malignant lymphoma were studied for the presence of terminal deoxynucleotidyl transferase (TdT) by biochemical and fluorescent antibody technics. TdT was detected in circulating blast cells from 73 of 77 patients with acute lymphoblastic leukemia, 24 of 72 patients with chronic myelogenous leukemia examined during the blastic phase of the disorder and in cell suspensions of lymph nodes from nine of nine patients with diffuse lymphoblastic lymphoma. Blast cells from six of 10 patients with acute undifferentiated leukemia were TdT positive, but the enzyme was found in only two of 55 patients with acute myeloblastic leukemia. TdT was not detected in other lymphocytic or granulocytic leukemias or in other types of malignant lymphomas. The fluorescent antibody assay for TdT permits rapid and specific identification of the enzyme in single cells. The TdT assay is clinically useful in confirming the diagnosis of acute lymphoblastic leukemia, evaluating patients with blastic chronic myelogenous leukemia, and distinguishing patients with lymphoblastic lymphoma, whose natural history includes rapid extranodal dissemination, from patients with other poorly differentiated malignant lymphomas.

Adolescent↗

Portal phlebothrombosis: the role of thrombectomy.

The causes, pathology, and clinical features of thrombosis within the portal venous system are discussed. When thrombosis starts in the periphery of the mesentery the extent of infarction in the bowel may be limited and treatment by resection of the thrombosed mesentery and adjacent gut may be successful. When the thrombosis is proximal thrombectomy is essential. A case is described in which proximal mesenteric venous thrombosis occurred in assoication with volvulus of a common embryonic midgut mesentery. Laparotomy was performed and a thrombus 25 cm long extending into the portal vein successfully removed by catheter thrombectomy.

Humans↗

Terminal deoxynucleotidyl transferase activity in human leukemic cells and in normal human thymocytes.

Peripheral leukocytes from patients with and without leukemia were assayed for presence of terminal deoxynucleotidyl transferase. Activity of this enzyme was detected in circulating leukemic cells from 11 to 13 patients with acute lymphoblastic leukemia, and in one of four with chronic myelogenous leukemia in blast crisis, but not in leukocytes from patients with other kinds of leukemia or in normal leukocytes. Its presence in a patient with chronic myelogenous leukemia in blast crisis lends biochemical support to the suggestion that some patients with chronic myelogenous leukemia undergo a lymphoblastic rather than a myeloblastic crisis. The thymocyte and leukemic-cell enzyme have the same substrate and primer preference. Normal thymocytes and leukemic cells contain two forms of terminal deoxynucleotidyl transferase that can be separated by phosphocellulose chromatography. The enzyme may provide a means for classifying leukemic cells on a biochemical basis independently of classic morphologic and clinical criteria.

Adolescent↗